Is SCHD a Good ETF to Buy?
With around $65.7 billion in net assets, Schwab’s US Dividend…
Buy
73
SMPNY Quote, Financials, Valuation and Earnings
Last price:
$13.01
Seasonality move
:
-2.04%
Day range:
$12.62 - $13.11
52-week range:
$8.25 - $14.30
Dividend yield:
2.63%
P/E ratio:
8.90x
P/S ratio:
0.79x
P/B ratio:
1.20x
Volume:
34.3K
Avg. volume:
49.6K
1-year change:
58.53%
Market cap:
$25.1B
Revenue:
$33.4B
EPS (TTM):
$1.47
| Period Ending | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $34.2B | $35.8B | $36.8B | $32.1B | $33.4B | |
| Revenue Growth (YoY) | 5.03% | 4.76% | 2.76% | -12.67% | 4.06% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $5B | $5.1B | $5.1B | $4.4B | $4.6B | |
| Other Inc / (Exp) | $1.5B | $1.7B | $1.6B | $1.4B | $1.7B | |
| Operating Expenses | $6B | $6.2B | $6.3B | $5.8B | $5.8B | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | $130.3M | $129.6M | $133.3M | $118.2M | $95.3M | |
| EBT. Incl. Unusual Items | $1.6B | $1.8B | $2.8B | $373.1M | $3.3B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $496.9M | $491M | $810.8M | $164.6M | $426.3M | |
| Net Income to Company | $1.6B | $1.8B | $2.8B | $373.1M | $3.3B | |
| Minority Interest in Earnings | -$6.2M | -$3.8M | -$15.7M | -$12.9M | -$13.9M | |
| Net Income to Common Excl Extra Items | $1.1B | $1.3B | $2B | $195.6M | $2.9B | |
| Basic EPS (Cont. Ops) | $0.51 | $0.62 | $0.96 | $0.10 | $1.45 | |
| Diluted EPS (Cont. Ops) | $0.51 | $0.62 | $0.96 | $0.10 | $1.45 | |
| Weighted Average Basic Share | $2.2B | $2.2B | $2.1B | $673.6M | $2B | |
| Weighted Average Diluted Share | $2.2B | $2.2B | $2.1B | $2B | $2B | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $1.8B | $2B | $3B | $491.4M | $3.4B | |
| Revenue (Reported) | $34.2B | $35.8B | $36.8B | $32.1B | $33.4B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $1.8B | $2B | $3B | $491.4M | $3.4B | |
| Period Ending | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | |
|---|---|---|---|---|---|---|
| Revenue | $9.5B | $9.8B | $9.3B | $10.3B | $9.5B | |
| Revenue Growth (YoY) | 3.42% | 2.94% | -5.19% | 10.7% | -7.71% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $1.3B | $1.3B | $1.1B | $1.2B | $1.2B | |
| Other Inc / (Exp) | $366.9M | $368.1M | $344.7M | $365.5M | $372.2M | |
| Operating Expenses | $1.2B | $1.3B | $1.2B | $1.2B | $1.2B | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | $32.3M | $34M | $29.5M | $24.6M | $22.7M | |
| EBT. Incl. Unusual Items | $592.3M | $701.4M | $170.2M | $926.9M | $911.9M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $152.3M | $163.6M | $61.6M | $191.2M | $137.6M | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -$65.1K | -$4.8M | -$3.1M | -$6.7M | -$4.3M | |
| Net Income to Common Excl Extra Items | $439.9M | $533M | $105.5M | $729.1M | $770M | |
| Basic EPS (Cont. Ops) | $0.20 | $0.25 | $0.05 | $0.36 | $0.39 | |
| Diluted EPS (Cont. Ops) | $0.20 | $0.25 | $0.05 | $0.36 | $0.39 | |
| Weighted Average Basic Share | $2.2B | $2.1B | $2.1B | $2B | $2B | |
| Weighted Average Diluted Share | $2.2B | $2.1B | $2.1B | $2B | $2B | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $624.6M | $735.4M | $199.8M | $951.5M | $934.6M | |
| Revenue (Reported) | $9.5B | $9.8B | $9.3B | $10.3B | $9.5B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $624.6M | $735.4M | $199.8M | $951.5M | $934.6M | |
| Period Ending | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | |
|---|---|---|---|---|---|---|
| Revenue | $34.5B | $36.1B | $36.3B | $33.1B | $32.8B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $5B | $5.1B | $4.9B | $4.5B | $4.5B | |
| Other Inc / (Exp) | $1.5B | $1.7B | $1.6B | $1.5B | $1.7B | |
| Operating Expenses | $6B | $6.2B | $6.1B | $5.8B | $5.7B | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | $129.9M | $131.2M | $128.8M | $113M | $93.4M | |
| EBT. Incl. Unusual Items | $1.8B | $1.9B | $2.3B | $1.2B | $3.3B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $550.3M | $502.9M | $712.6M | $296.2M | $380.8M | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -$2M | -$8.6M | -$14.1M | -$16.4M | -$11.8M | |
| Net Income to Common Excl Extra Items | $1.3B | $1.4B | $1.6B | $841.3M | $2.9B | |
| Basic EPS (Cont. Ops) | $0.59 | $0.67 | $0.76 | $0.43 | $1.47 | |
| Diluted EPS (Cont. Ops) | $0.59 | $0.67 | $0.76 | $0.42 | $1.47 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $2B | $2.1B | $2.4B | $1.3B | $3.4B | |
| Revenue (Reported) | $34.5B | $36.1B | $36.3B | $33.1B | $32.8B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $2B | $2.1B | $2.4B | $1.3B | $3.4B | |
| Period Ending | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | |
|---|---|---|---|---|---|---|
| Revenue | $9.5B | $9.8B | $9.3B | $10.3B | $9.5B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $1.3B | $1.3B | $1.1B | $1.2B | $1.2B | |
| Other Inc / (Exp) | $366.9M | $368.1M | $344.7M | $365.5M | $372.2M | |
| Operating Expenses | $1.2B | $1.3B | $1.2B | $1.2B | $1.2B | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | $32.3M | $34M | $29.5M | $24.6M | $22.7M | |
| EBT. Incl. Unusual Items | $592.3M | $701.4M | $170.2M | $926.9M | $911.9M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $152.3M | $163.6M | $61.6M | $191.2M | $137.6M | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -$65.1K | -$4.8M | -$3.1M | -$6.7M | -$4.3M | |
| Net Income to Common Excl Extra Items | $439.9M | $533M | $105.5M | $729.1M | $770M | |
| Basic EPS (Cont. Ops) | $0.20 | $0.25 | $0.05 | $0.36 | $0.39 | |
| Diluted EPS (Cont. Ops) | $0.20 | $0.25 | $0.05 | $0.36 | $0.39 | |
| Weighted Average Basic Share | $2.2B | $2.1B | $2.1B | $2B | $2B | |
| Weighted Average Diluted Share | $2.2B | $2.1B | $2.1B | $2B | $2B | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $624.6M | $735.4M | $199.8M | $951.5M | $934.6M | |
| Revenue (Reported) | $9.5B | $9.8B | $9.3B | $10.3B | $9.5B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $624.6M | $735.4M | $199.8M | $951.5M | $934.6M | |
| Period Ending | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $8.6B | $9.7B | $9.6B | $9.4B | $8.1B | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $8.6B | $9.7B | $9.6B | $9.4B | $8.1B | |
| Property Plant And Equipment | $3.5B | $3.3B | $2.9B | $2.7B | $2.5B | |
| Long-Term Investments | $73.7B | $81.9B | $78.2B | $73.6B | $75.5B | |
| Goodwill | $1.6B | $1.5B | $1.2B | $1.5B | $1.1B | |
| Other Intangibles | $2.2B | $2.3B | $2.3B | $2.6B | $2.3B | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $110.8B | $118.9B | $113B | $100.2B | $98B | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | -- | -- | -- | -- | -- | |
| Long-Term Debt | $4.7B | $4.8B | $4.4B | $4.6B | $4.5B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $95.9B | $100.5B | $96.2B | $85.8B | $79B | |
| Common Stock | $925.7M | $906.9M | $819.7M | $750.8M | $661M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | $14.8B | $18.3B | $16.6B | $14.3B | $18.8B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $139.1M | $111.9M | $100.2M | $118.8M | $106.5M | |
| Total Equity | $14.9B | $18.4B | $16.7B | $14.4B | $19B | |
| Total Liabilities and Equity | $110.8B | $118.9B | $113B | $100.2B | $98B | |
| Cash and Short Terms | $8.6B | $9.7B | $9.6B | $9.4B | $8.1B | |
| Total Debt | $4.7B | $4.8B | $4.4B | $4.6B | $4.5B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $10.2B | $11.2B | $9B | $9B | $8.1B | |
| Short Term Investments | $200.2M | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $10.9B | $11.2B | $9B | $9B | $8.1B | |
| Property Plant And Equipment | $3.5B | $3.2B | $2.5B | $2.4B | $2.7B | |
| Long-Term Investments | $79.5B | $83.3B | $67B | $71.8B | $81.8B | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | $3.8B | $3.8B | $3.3B | $3.7B | $3.6B | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $118B | $123.2B | $102.7B | $95.3B | $106.2B | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | -- | -- | -- | -- | -- | |
| Long-Term Debt | $4.8B | $4.8B | $3.9B | $4.6B | $4.9B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $101.7B | $104B | $89.9B | $79.2B | $85.2B | |
| Common Stock | $946.7M | $893.7M | $692.5M | $669.7M | $700.5M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $113.3M | $103.6M | $96.2M | $119.3M | $114.4M | |
| Total Equity | $16.3B | $19.2B | $12.8B | $16.1B | $21B | |
| Total Liabilities and Equity | $118B | $123.2B | $102.7B | $95.3B | $106.2B | |
| Cash and Short Terms | $10.4B | $11.2B | $9B | $9B | $8.1B | |
| Total Debt | $4.8B | $4.8B | $3.9B | $4.6B | -- | |
| Period Ending | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $1.6B | $1.8B | $2.8B | $373.1M | $3.3B | |
| Depreciation & Amoritzation | $601.4M | $648.1M | $716.8M | $606.3M | $652.3M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $3.3B | $5.9B | $5.3B | $2.8B | $3.3B | |
| Capital Expenditures | $248.8M | $231.5M | $191.5M | $178.8M | $214.7M | |
| Cash Acquisitions | -$8.5M | -$219.5M | -- | -$600.9M | $208.8M | |
| Cash From Investing | -$1.3B | -$3.4B | -$3.1B | -$1.9B | -$3.4B | |
| Dividends Paid (Ex Special Dividend) | -$474.5M | -$528.2M | -$611.6M | -$590.4M | -$643.1M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $36.8K | -- | -- | $1.7B | $508.4M | |
| Long-Term Debt Repaid | -$349.7M | -$305.5M | -$271.5M | -$1.4B | -$44.7M | |
| Repurchase of Common Stock | -$334.2M | -$333.2M | -$538.3M | -$429.7M | -$173.5M | |
| Other Financing Activities | -$898.3M | $323.2M | -$86.4M | $66.7M | -$241.7M | |
| Cash From Financing | -$2.1B | -$891.4M | -$1.5B | -$684M | -$607.1M | |
| Beginning Cash (CF) | $9.1B | $9.1B | $10B | $8.9B | $8.8B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$131.4M | $1.6B | $724.8M | $236.2M | -$772.4M | |
| Ending Cash (CF) | $8.9B | $10.5B | $10.8B | $9.4B | $8.3B | |
| Levered Free Cash Flow | $3B | $5.7B | $5.2B | $2.6B | $3.1B | |
| Period Ending | 2007-03-31 | 2008-03-31 | 2009-03-31 | 2010-03-31 | 2011-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -$702M | |
| Depreciation & Amoritzation | -- | -- | -- | -- | $63.6M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | -- | -$173.8M | |
| Capital Expenditures | -- | -- | -- | -- | $76.9M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | $1.1B | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | $12.4M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | $137.5K | |
| Other Financing Activities | -- | -- | -- | -- | -$4.4M | |
| Cash From Financing | -- | -- | -- | -- | $8.1M | |
| Beginning Cash (CF) | -- | -- | -- | -- | $3.9B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -$7.5M | |
| Additions / Reductions | -- | -- | -- | -- | $961.3M | |
| Ending Cash (CF) | -- | -- | -- | -- | $4.6B | |
| Levered Free Cash Flow | -- | -- | -- | -- | -$250.7M | |
| Period Ending | 2007-12-31 | 2008-12-31 | 2009-12-31 | 2010-12-31 | 2011-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | -- | -- | |
| Capital Expenditures | -- | -- | -- | $77.8M | $76.9M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -$310.8M | $12.4M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -- | -- | |
| Period Ending | 2021-01-08 | 2022-01-08 | 2023-01-08 | 2024-01-08 | ||
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | -- | -- | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -- | -- | |
Get SMPNY Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
SMPNY
Sector
P/E ratio
8.90x
--
PEG ratio
0.04x
--
P/B ratio
1.20x
--
Price / LTM sales
0.79x
--
Growth Metrics
SMPNY
Sector
Revenue growth
-7.71%
--
Earnings growth
6.84%
--
Revenue (5-year growth)
0.55%
--
Earnings forecast
--
--
Profitability
SMPNY
Sector
Profitability FY 2024
--
--
Return on invested capital
13.24%
--
Return on assets
2.97%
--
Return on equity
17.15%
--
Earnings Date
Last Earnings Date
Nov
19
Next Earnings Date
Feb
14
Estimated Next Earnings Date
Feb
18
Balance Sheet
SMPNY
Sector
Total cash
$8.1B
--
Short term investments
--
--
Total assets
$98B
--
Long term debt
--
--
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is NAIL a Good ETF to Buy?
If you’re thinking about buying the NAIL ETF, this article…
3 High Dividend Dow Jones Stocks
Thanks to surging stock prices over the past two years,…
Stock Ideas
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 40x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 117x
Sell
43
Is MSFT Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 36x
Alerts
Buy
57
NARI alert for Jan 8
Inari Medical [NARI] is up 22.25% over the past day.
Buy
69
UNF alert for Jan 8
UniFirst [UNF] is up 20.59% over the past day.
Sell
31
APOG alert for Jan 8
Apogee Enterprises [APOG] is down 19.13% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
